Gastrointestinal Cancer

>

Latest News

Antitumor activity was observed in patients with gastroesophageal adenocarcinoma treated with the combination regardless of chemotherapy type.
Zanidatamab Displays Safety, Efficacy in HER2-Expressing Gastric Cancer

May 19th 2025

Antitumor activity was observed in patients with gastroesophageal adenocarcinoma treated with the combination regardless of chemotherapy type.

For patients with right-sided CRC tumors, no significant progression-free survival difference was observed between the cetuximab and FOLFIRI-only groups.
Cetuximab β/FOLFIRI Prolongs Survival vs FOLFIRI in RAS/BRAF Wild-Type mCRC

May 19th 2025

The trial initiation is based on phase 1/2 IDeate-PanTumor01 trial results presented at the 2022 and 2023 European Society for Medical Oncology Congress.
Phase 3 IDeate-Esophageal01 Trial Initiated for Unresectable ESCC

May 19th 2025

Data from the POD1UM-303/InterAACT2 trial support the approval of retifanlimab/chemotherapy in this squamous cell carcinoma of the anal canal population.
FDA OKs Retifanlimab Combo in Recurrent/Metastatic Anal Cancer

May 15th 2025

The safety profile of TFOX was consistent with data reported in previous studies, and no new safety signals were identified.
TFOX Regimen Enhances Efficacy vs FOLFOX in HER2-Negative Gastric Cancer

May 11th 2025

Latest CME Events & Activities

Community Practice Connections™: 9th Annual School of Gastrointestinal Oncology®

View More

BURST CME™: Illuminating the Crossroads of Precision Medicine and Targeted Treatment Options in Metastatic CRC

View More

Go To PER in Chicago

May 30, 2025 - June 3, 2025

Register Now!

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Community Practice Connections™: 14th Asia-Pacific Primary Liver Cancer Expert Meeting

View More

PER® Liver Cancer Tumor Board: How Do Evolving Data for Immune-Based Strategies in Resectable and Unresectable HCC Impact Multidisciplinary Patient Management Today… and Tomorrow?

View More

Show Me the Data™: Bridging Clinical Gaps Along the Continuum From Resectable, Early Stage to Advanced Gastric/Gastroesophageal Junction Cancers

View More

<1
...
5253545556